NOW ACCEPTING INVESTORS Learn about this emerging technology
BIOLIFE4D is committed to perfecting the technology to make viable organ replacement a safe, accessible and affordable reality. With BIOLIFE4D, a patient-specific, fully functioning heart will be created through 3D bioprinting and the patient’s own cells, eliminating the challenges of organ rejection and long donor waiting lists that plague existing organ transplant methods.
BIOLIFE4D is now accepting investors. Enter your information to begin this process or speak with a Biolife4D representative. Submitting your information does not indicate any financial obligation to invest.
Watch our video below.
Your information is requested if you wish to invest, or to learn more about this opportunity.
Your indication of interest involves no obligation to invest. No money or other consideration is being solicited, and, if sent, will not be accepted. No sales of the securities will be made or commitment to purchase accepted until qualification of the offering statement by the Securities and Exchange Commission and approval of any other required government or regulatory agency. An indication of interest is non-binding and involves no obligation or commitment of any kind. No offer of securities will be made without a registration statement. By checking the box and clicking the “Submit” button you agree (1) you are interested in the potential offering and consent to being contacted by BIOLIFE4D both before and after the offering is qualified by the United States Securities and Exchange Commission, (2) you understand that no money or other consideration is being solicited at this time, and if sent, will not be accepted, and (3) you understand that your indication of interest involves no financial obligation or commitment of any kind.